Alexandra Kropotova - 06 Jun 2022 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Chief Medical Officer
Signature
/s/ Alexandra Kropotova
Issuer symbol
SABS
Transactions as of
06 Jun 2022
Net transactions value
$0
Form type
4
Filing time
07 Jun 2022, 20:00:13 UTC
Previous filing
13 Dec 2021
Next filing
15 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Award $0 +300,000 $0.000000 300,000 06 Jun 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Unit ("RSU") award under the 2021 Equity Incentive Plan, which vests over a four-year service period, with the first 25% vesting on June 6, 2023, and the remaining vesting in even monthly increments thereafter. The RSU award is subject to the reporting person's continued employment through the vesting date.
F2 Each RSU represents a contingent right to receive one share of the Issuer's common stock.